1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 12 Hits
  • 検索条件 : 絞込み (MeSH = Cancer-Associated Fibroblasts / pathology)
生物種 リソース名 タイトル
ヒト・動物細胞 HSC-2(RCB1945) A landmark in drug discovery based on complex natural product synthesis.
ヒト・動物細胞 LLC(RCB0558) Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.
ヒト・動物細胞 PANC-1(RCB2095) LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer.
ヒト・動物細胞 WA-hT(RCB2279) A Cancer Invasion Model Combined with Cancer-Associated Fibroblasts Aggregates Incorporating Gelatin Hydrogel Microspheres Containing a p53 Inhibitor.
ヒト・動物細胞 PK-8(RCB2700) Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.
ヒト・動物細胞 293T(RCB2202) , PK-8(RCB2700) Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts.
ヒト・動物細胞 hPSC-5(RCB3588) Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.
ヒト・動物細胞 PC-9(RCB4455) Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
ヒト・動物細胞 293gp(RCB2354) An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
ヒト・動物細胞 TFK-1(RCB2537) , HuCCT1(RCB1960) Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
遺伝子材料 , ヒト・動物細胞 CSII-CMV-RfA-IRES2-Venus (RDB04388). , 293T(RCB2202) A novel method to generate single-cell-derived cancer-associated fibroblast clones.
遺伝子材料 pENTR4-H1 (RDB04395) , CS-RfA-EG (RDB04391) , CSII-CMV-RfA-IRES2-Venus (RDB04388) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394). CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.